You are here

Data on heart benefits of Amgen drug key to unlocking sales

New York

DATA that should help unlock the sales potential of a potent new cholesterol medicine will be unveiled at the American College of Cardiology meeting this week as the future of the only rival drug rests with the courts in an ongoing patent dispute.

Highly anticipated...

Market voices on: